173 related articles for article (PubMed ID: 26238930)
21. A comprehensive study of iRGD-modified liposomes with improved chemotherapeutic efficacy on B16 melanoma.
Dai W; Fan Y; Zhang H; Wang X; Zhang Q; Wang X
Drug Deliv; 2015 Jan; 22(1):10-20. PubMed ID: 24735248
[TBL] [Abstract][Full Text] [Related]
22. Efficient downregulation of VEGF in retinal pigment epithelial cells by integrin ligand-labeled liposome-mediated siRNA delivery.
Chen CW; Yeh MK; Shiau CY; Chiang CH; Lu DW
Int J Nanomedicine; 2013; 8():2613-27. PubMed ID: 23901275
[TBL] [Abstract][Full Text] [Related]
23. PEGylated cationic liposomes robustly augment vaccine-induced immune responses: Role of lymphatic trafficking and biodistribution.
Zhuang Y; Ma Y; Wang C; Hai L; Yan C; Zhang Y; Liu F; Cai L
J Control Release; 2012 Apr; 159(1):135-42. PubMed ID: 22226776
[TBL] [Abstract][Full Text] [Related]
24. Indocyanine Green-Loaded Liposomes for Light-Triggered Drug Release.
Lajunen T; Kontturi LS; Viitala L; Manna M; Cramariuc O; Róg T; Bunker A; Laaksonen T; Viitala T; Murtomäki L; Urtti A
Mol Pharm; 2016 Jun; 13(6):2095-107. PubMed ID: 27097108
[TBL] [Abstract][Full Text] [Related]
25. Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor.
Hamano N; Negishi Y; Fujisawa A; Manandhar M; Sato H; Katagiri F; Nomizu M; Aramaki Y
Int J Pharm; 2012 May; 428(1-2):114-7. PubMed ID: 22421321
[TBL] [Abstract][Full Text] [Related]
26. RGD-modified PEG-PAMAM-DOX conjugates: in vitro and in vivo studies for glioma.
Zhang L; Zhu S; Qian L; Pei Y; Qiu Y; Jiang Y
Eur J Pharm Biopharm; 2011 Oct; 79(2):232-40. PubMed ID: 21496485
[TBL] [Abstract][Full Text] [Related]
27. A tumor vasculature targeted liposome delivery system for combretastatin A4: design, characterization, and in vitro evaluation.
Nallamothu R; Wood GC; Pattillo CB; Scott RC; Kiani MF; Moore BM; Thoma LA
AAPS PharmSciTech; 2006 Apr; 7(2):E32. PubMed ID: 16796350
[TBL] [Abstract][Full Text] [Related]
28. Delivery of RGD-modified liposome as a targeted colorectal carcinoma therapy and its autophagy mechanism.
Ren Y; Yuan B; Hou S; Sui Y; Yang T; Lv M; Zhou Y; Yu H; Li S; Peng H; Chang N; Liu Y
J Drug Target; 2021 Sep; 29(8):863-874. PubMed ID: 33507113
[TBL] [Abstract][Full Text] [Related]
29. Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.
Garg A; Tisdale AW; Haidari E; Kokkoli E
Int J Pharm; 2009 Jan; 366(1-2):201-10. PubMed ID: 18835580
[TBL] [Abstract][Full Text] [Related]
30. Increased tumor targeted delivery using a multistage liposome system functionalized with RGD, TAT and cleavable PEG.
Mei L; Fu L; Shi K; Zhang Q; Liu Y; Tang J; Gao H; Zhang Z; He Q
Int J Pharm; 2014 Jul; 468(1-2):26-38. PubMed ID: 24709209
[TBL] [Abstract][Full Text] [Related]
31. Hybrid polypeptide micelles loading indocyanine green for tumor imaging and photothermal effect study.
Wu L; Fang S; Shi S; Deng J; Liu B; Cai L
Biomacromolecules; 2013 Sep; 14(9):3027-33. PubMed ID: 23941524
[TBL] [Abstract][Full Text] [Related]
32. PHSCNK-Modified and doxorubicin-loaded liposomes as a dual targeting system to integrin-overexpressing tumor neovasculature and tumor cells.
Dai W; Yang T; Wang X; Wang J; Zhang X; Zhang Q
J Drug Target; 2010 May; 18(4):254-63. PubMed ID: 19824864
[TBL] [Abstract][Full Text] [Related]
33. Near-infrared image-guided delivery and controlled release using optimized thermosensitive liposomes.
Turner DC; Moshkelani D; Shemesh CS; Luc D; Zhang H
Pharm Res; 2012 Aug; 29(8):2092-103. PubMed ID: 22451250
[TBL] [Abstract][Full Text] [Related]
34. Preparation and characterization of phospholipid-conjugated indocyanine green as a near-infrared probe.
Suganami A; Toyota T; Okazaki S; Saito K; Miyamoto K; Akutsu Y; Kawahira H; Aoki A; Muraki Y; Madono T; Hayashi H; Matsubara H; Omatsu T; Shirasawa H; Tamura Y
Bioorg Med Chem Lett; 2012 Dec; 22(24):7481-5. PubMed ID: 23122858
[TBL] [Abstract][Full Text] [Related]
35. Targeting and Internalization of Liposomes by Bladder Tumor Cells Using a Fibronectin Attachment Protein-Derived Peptide-Lipopolymer Conjugate.
Lee Y; Kischuk E; Crist S; Ratliff TL; Thompson DH
Bioconjug Chem; 2017 May; 28(5):1481-1490. PubMed ID: 28475311
[TBL] [Abstract][Full Text] [Related]
36. Enhanced legumain-recognition and NIR controlled released of cisplatin-indocyanine nanosphere against gastric carcinoma.
Shi T; Gu L; Sun Y; Wang S; You C; Zhang X; Zhu J; Sun B
Eur J Pharmacol; 2017 Jan; 794():184-192. PubMed ID: 27894812
[TBL] [Abstract][Full Text] [Related]
37. Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies.
Zhang YF; Wang JC; Bian DY; Zhang X; Zhang Q
Eur J Pharm Biopharm; 2010 Mar; 74(3):467-73. PubMed ID: 20064608
[TBL] [Abstract][Full Text] [Related]
38. [Efficacy of internalized RGD-modified echogenic liposomes in diagnosis and treatment in a mouse model of rheumatoid arthritis].
Gan Z; Wu H; Wu HH; Zhou MJ; Yan F; Liu HM
Nan Fang Yi Ke Da Xue Xue Bao; 2017 Oct; 37(10):1283-1289. PubMed ID: 29070455
[TBL] [Abstract][Full Text] [Related]
39. Indocyanine green loaded liposome nanocarriers for photodynamic therapy using human triple negative breast cancer cells.
Shemesh CS; Hardy CW; Yu DS; Fernandez B; Zhang H
Photodiagnosis Photodyn Ther; 2014 Jun; 11(2):193-203. PubMed ID: 24657627
[TBL] [Abstract][Full Text] [Related]
40. Detection of peritoneal dissemination with near-infrared fluorescence laparoscopic imaging using a liposomal formulation of a synthesized indocyanine green liposomal derivative.
Hoshino I; Maruyama T; Fujito H; Tamura Y; Suganami A; Hayashi H; Toyota T; Akutsu Y; Murakami K; Isozaki Y; Akanuma N; Takeshita N; Toyozumi T; Komatsu A; Matsubara H
Anticancer Res; 2015 Mar; 35(3):1353-9. PubMed ID: 25750285
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
